Skip to content
OpenCapital
Get started

MiMedx Group MDXG Gross margin

Gross margin at other companies

IAR
Integra LifeSciencesIART
51.9%-1.6pp
Artivion logo
ArtivionAORT
64.6%+0.6pp
Solventum logo
SolventumSOLV
53.7%-0.9pp
Vericel logo
VericelVCEL
74.8%+2.3pp
Enovis logo
EnovisENOV
60.5%+4.0pp
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
76.4%+1.8pp

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Calculated from MiMedx Group’s reported figures.

gross profit/total revenue=81%

Based on trailing twelve months.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's gross margin?
MiMedx Group (MDXG) reported gross margin of 81% in Q1 2026.
How has MiMedx Group's gross margin changed year-over-year?
MiMedx Group's gross margin decreased by 1.1% year-over-year, from 81.9% to 81%.
What is the long-term trend for MiMedx Group's gross margin?
Over 5 years (2020 to 2025), MiMedx Group's gross margin has grown at a -0.4% compound annual growth rate (CAGR), from 84.2% to 82.6%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.